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ctin participates in several intracellular trafﬁcking
pathways. We now ﬁnd that actin, bound to the
surface of puriﬁed yeast vacuoles in the absence of
cytosol or cytoskeleton, regulates the last compartment
mixing stage of homotypic vacuole fusion. The Cdc42p
GTPase is known to be required for vacuole fusion. We now
show that proteins of the Cdc42p-regulated actin remodeling
cascade (Cdc42p 
 
→
 
 Cla4p 
 
→
 
 Las17p/Vrp1p 
 
→
 
 Arp2/3
complex 
 
→
 
 actin) are enriched on isolated vacuoles. Vacuole
fusion is dramatically altered by perturbation of the vacuole-
A
 
bound actin, either by mutation of the 
 
ACT1
 
 gene, addition of
speciﬁc actin ligands such as latrunculin B or jasplakinolide,
antibody to the actin regulatory proteins Las17p (yeast
Wiskott-Aldrich syndrome protein) or Arp2/3, or deletion of
actin regulatory genes. On docked vacuoles, actin is enriched
at the “vertex ring” membrane microdomain where fusion
occurs and is required for the terminal steps leading to
membrane fusion. This role for actin may extend to other
trafﬁcking systems.
 
Introduction
 
Proteins are sorted by selective vesicular traffic (Jahn and
Sudhof, 1999). The membrane fusion stage of trafficking is
unexpectedly complex. It requires the coordinated action of
chaperones (such as NSF and 
 
 
 
-SNAP), SNAREs, GTPases
(Rab and Rho families), lipids (steroid and phosphoinositides),
and regulated calcium fluxes.
Actin has a central role in several trafficking events
(Qualmann et al., 2000; Foti et al., 2001; Goode and Rodal,
2001; Lechler et al., 2001). Actin filaments are required for the
transport and spatial targeting of secretory proteins (Pruyne
et al., 1998; Guo et al., 2001), organelle inheritance during cell
division (Catlett and Weisman, 2000), and the maintenance of
Golgi structure (Mullholland et al., 1997; Valderrama et al.,
1998). In different systems, membrane fusion has been
shown to be promoted by stabilization of F-actin (Koffer et
al., 1990; Jahraus et al., 2001), F-actin disassembly (Vitale et
al., 1991; Muallem et al., 1995), or actin remodeling, i.e.,
disassembly plus reassembly (Bernstein et al., 1998; Lang et al.,
2000). Actin remodeling also accompanies synaptic stimulation
(Colicos et al., 2001). Actin ligands can modulate phagosome–
endosome fusion in vitro (Jahraus et al., 2001), and actin binds
to purified endosomal and lysosomal vesicles, an association
which can nucleate actin polymerization (Mehrabian et al.,
1984; Taunton, 2001). Actin and myosin V are involved
directly in vacuole movement into the bud during cell division
(Hill et al., 1996; Catlett et al., 2000). Rho-GTPases regulate
actin rearrangement (Hall, 1998) by signaling to multiple
downstream effector complexes such as the Wiskott-Aldrich
syndrome protein (WASp)* and the Arp2/3 complex (Higgs
and Pollard, 1999). In each of these studies, it was assumed
that the relevant actin molecules are cytosolic or cytoskeletal,
though none of the data precludes a role for organelle-
bound actin.
We study membrane fusion with vacuoles from 
 
Saccharo-
myces cerevisiae
 
 (Wickner and Haas, 2000). Purified yeast
vacuoles undergo homotypic fusion in simple buffers
containing ATP. All of the proteins and lipids needed for
fusion are bound to the vacuole membrane. The reaction occurs
in three stages termed priming, docking, and fusion. Priming,
initiated by the ATPase Sec18p, releases Sec17p (Mayer et al.,
1996) and disassembles a cis complex of SNAREs (Ungermann
et al., 1998a). Priming liberates the “HOPS” complex (for
homotypic fusion and vacuole protein sorting)/VPS class C
complex (Sato et al., 2000; Seals et al., 2000), which then
associates with GTP-bound Ypt7p to initiate docking (Price
et al., 2000). Completion of docking requires SNAREs
(Ungermann et al., 1998b), the vacuole membrane potential
(Ungermann et al., 1999), phosphoinositides (Mayer et al.,
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2000), and the Rho-GTPases Cdc42p and Rho1p (Eitzen et
al., 2001; Müller et al., 2001). Docking culminates in a
transient release of vacuole lumenal calcium (Peters and
Mayer, 1998). Calcium activates calmodulin, which binds
to the V
 
0
 
 domain of the vacuolar ATPase, triggering the for-
mation of trans-pairs of V
 
0
 
 plus the t-SNARE Vam3p, lead-
ing to organelle fusion (Peters et al., 2001).
Two Rho-GTPases which are required for vacuole fusion,
Cdc42p and Rho1p (Eitzen et al., 2001; Müller et al.,
2001), can regulate actin structure (Pringle et al., 1995; Hel-
liwell et al., 1998) through a well-studied cascade which in-
cludes Las17p/Bee1p (yeast WASp) and the Arp2/3 complex
(Fig. 1). A recent screen of a library of yeast strains with de-
fined gene deletions (Seeley et al., 2002) suggested that this
cascade of actin regulatory genes is needed to maintain nor-
mal vacuole structure. We now report that the proteins of
this regulatory cascade, from Cdc42p to Las17p and Arp2/
3p, and actin itself, are found on purified yeast vacuoles, are
essential for fusion, and allow actin action at the final stage
of the fusion pathway. This role of actin in vacuole fusion
may extend to other membrane fusion events.
 
Results
 
Cdc42p, a Rho-GTPase which regulates actin structure, is
required for vacuole fusion and normal vacuole copy num-
ber in vivo (Eitzen et al., 2001; Müller et al., 2001). These
studies showed that the fusion of purified vacuoles was
blocked by antibodies to Cdc42p and that vacuoles which
were isolated from strains with temperature-sensitive Cdc42p
were thermolabile for fusion. Fig. 1 depicts a schematic
pathway in which Cdc42p and phosphatidylinositol 4,5-bis-
phosphate (PI[4,5]P2) govern a regulatory cascade which
controls actin remodeling. Genetic (Seeley et al., 2002) and
biochemical (Mayer et al., 2000) data show that PI(4,5)P2 is
required for vacuole fusion, possibly as a guanine nucleotide
exchange factor for Cdc42p (Zheng et al., 1996) or an acti-
vating ligand for Las17p. Vacuoles have abnormal structure
in strains with gene deletions for Cla4p, Vrp1p, Myo3p,
Figure 1. A signaling pathway which regulates actin remodeling. 
Arrows depict known protein interactions. Dashed lines and 
arrows depict pathways seen in mammalian cells. Lines show 
other interacting factors.
Figure 2. Actin affects vacuole morphology. (A) Vacuole morphology 
of gene deletion or actin or LAS17 mutant strains. The strains RLY 574 
(arp2 ), DDY2266 (las17–16), GEY1290 (myo3 ), GEY1090 (myo5 ), 
GEY4840 (sac2 ), GEY1290 (sac6 ), GEY3370 (vrp1 ), GEY2980 
(cla4 ), GEY3700 (arc18 ), GEY0394–101 (act1–101), GEY0394–157 
(act1–157), and the wild-type strain BY4742 (WT) were grown 
overnight in YPD, stained with FM4–46 and examined for vacuole 
morphology. The width of the field shown in each of the nine panels is 
25  m. (B) Immunoblot analysis of vacuoles and whole cell lysate 
prepared from strain GEY6024 for actin, actin signaling proteins 
(Vrp1p, Las17p, Arp3p, Cla4p, and Cdc42p), vacuolar proteins (Ypt7p 
and CPY), and a cytosolic chaperone (Ssa1p). 
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Vrp1p, also binds directly to Las17p (Madania et al., 1999;
Lechler et al., 2001; Martinez-Quiles et al., 2001). Las17p
and Vrp1p regulate actin remodeling through activation of
the Arp2/3 complex (Winter et al., 1999; Evangelista et al.,
2000). Because actin and its regulatory proteins might affect
vacuole structure either directly or indirectly through altered
endocytic or biosynthetic protein and lipid delivery to the
vacuole, we have characterized their presence and functions
on the purified organelle. In accord with the finding that
isolated vacuoles bear Cdc42p (Müller et al., 2001), we find
that Cla4p, Vrp1p, Las17p, Arp3p, and actin itself are
present on purified vacuoles (Fig. 2 B) at levels which meet
or exceed their concentration in the whole cell. However,
only a small portion of the total cellular complement of
Myo5p, Arp2p, Arc18p, Sac2p, or Sac6p or when point mu-
tations are introduced into actin (Fig. 2 A). Vacuoles are
also fragmented in the 
 
las17–16
 
 strain, which contains a
COOH-terminal 21 amino acid truncation that removes the
Arp2/3 activation domain of Las17p (Fig. 2 A) (Duncan et
al., 2001). Each of these proteins directly modulates actin
structure or its assembly (Adams et al., 1989; Higgs and Pol-
lard, 1999, 2000; Vaduva et al., 1999; Evangelista et al.,
2000; Prehoda et al., 2000; Rozelle et al., 2000). Cla4p, a
p20-activated kinase (PAK), is a downstream effector of
Cdc42p (Gladfetter et al., 2001; Mosch et al., 2001). Cla4p
modifies Myo3p and Myo5p (Lechler et al., 2000), which
interact with Las17p/Bee1p, the yeast homologue of WASp
(Madania et al., 1999; Lechler et al., 2000). Yeast verprolin,
Figure 3. Actin regulatory proteins are 
required for vacuole fusion. (A) Las17p 
antibodies inhibit vacuole fusion. 
Standard fusion reactions were incubated 
at 27 C in the presence of increasing 
concentrations of anti-LAS17 peptide 
antibodies (left) or anti-YPT7 peptide 
antibodies (right) that were either 
untreated ( ) or were immunodepleted 
by incubation with immobilized LAS17 
peptide ( ) or immobilized YPT7 peptide 
( ) (as described in Materials and 
methods). Titration curves for immuno-
depleted samples were normalized by 
volume to the nonimmunodepleted 
samples. (B) Las17p antibody no longer 
inhibits after docking. Standard fusion 
reactions (7 ) were first incubated with 
either 50  g/ml anti-Sec18p, 64  g/ml 
anti-Ypt7 antibodies, or 3.5 mM BAPTA 
for 30, 35, or 45 min, respectively. 
Sec18p (10  g/ml), Ypt7p peptide 
(30  g/ml), or 4 mM calcium was then 
added to reverse these blocks, and 
aliquots (30  l) were immediately 
distributed into tubes containing the 
indicated second inhibitors and incubated 
at 27 C (lanes 2–7) or on ice (lane 1) for 
90 min total. (C) Bypass of Las17p 
function. Fusion reactions with 8  g/ml 
IB2 and 1  g/ml Sec18p were incubated 
with increasing concentrations of 
anti-Las17 antibodies in the presence 
or absence of 1 mg/ml calmodulin, 
0.5 mg/ml GST, 0.5 mg/ml GST–WCA, 
or 0.5 mg/ml GST–CA. (D) Arp3p 
antibodies inhibit vacuole fusion. Standard 
fusion reactions were incubated with an 
increasing amount of NH2- and COOH-
terminal Arp3p antibodies which had 
been dialyzed into PS buffer and used 
directly or heat denatured by incubation 
at 95 C for 5 min. 
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these proteins is vacuolar, since this organelle comprises 
 
 
 
1/
30th of the cell protein. Actin on the vacuole is thus accom-
panied by at least a proportionate amount of its normal reg-
ulatory proteins, even though both actin and its regulatory
proteins, such as Las17p and Arp2/3 complex, are largely
found in cytoplasmic cables and plasma membrane patches
(Winter et al., 1999).
To test the role of these proteins in vacuole fusion, we pre-
pared an antibody to a peptide from the NH
 
2
 
-terminal re-
gion of Las17p. We assay homotypic fusion of vacuoles by
mixing vacuoles from two strains (Wickner and Haas, 2000).
One strain has normal vacuolar lumenal proteases but is de-
leted for the gene encoding the Pho8p phosphatase. The
other strain is deleted for the vacuolar lumenal protease
Pep4p and therefore accumulates catalytically inactive pro-
Pho8p. During incubation with ATP, fusion allows the
Pep4p protease to gain access to pro-Pho8p, yielding mature,
active phosphatase which is assayed colorimetrically. Vacuole
fusion is inhibited by antibodies to Las17p (Fig. 3 A, left, No
depletion). The inhibitory antibodies can be specifically de-
pleted by beads bearing the immobilized peptide to which
the antibodies were raised (Fig. 3 A, left, compare depletion
by immobilized LAS17 peptide with YPT7 peptide).
Reversible inhibitors of the vacuole fusion reaction allow
us to determine the last reaction stage that is sensitive to
anti-Las17p antibodies (Fig. 3 B). Staging experiments were
performed with three reversible inhibitors: antibodies to the
priming catalyst Sec18p, antibodies to the docking catalyst
Ypt7p, or the fusion inhibitor BAPTA. Incubation of vacu-
oles with anti-Sec18p antibodies prevents priming. The fu-
sion reaction pathway resumes when excess Sec18p is added
(Fig. 3 B, top, lane 2). This reaction remains sensitive to
Figure 4. Actin mutations impair vacuole fusion. (A) Vacuoles 
isolated from strains bearing wild-type actin (GEY0394/0398), act1–157 
(GEY0394–157/0398–157), or act1–101 (GEY0394–101/0398–101) 
were tested for fusion in the absence of additional soluble components 
(None) or in the presence of IB2, calmodulin, Sec18p, P.C. (IB2,
Sec18p, and Cmd1p), or cytosol (0.5 mg/ml). (B) Standard fusion reac-
tions of ACT1 or act1–157 vacuoles are blocked by inhibitors of the 
normal fusion pathway. (C) Immunoblot analysis of purified 
vacuoles (5  g/lane) isolated from strain GEY0394 (ACT1) or the actin 
mutant strains GEY0394–157 (act1–157), and GEY0394–101 (act1–101). 
(D) Immunoblot analysis of whole cell lysates (30  g/lane) from the 
strains in C. 
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anti-Las17p antibodies (Fig. 3 B, top, lane 7), showing that
Las17p is required for the normal fusion reaction pathway.
Vacuoles undergo priming in fusion reactions incubated
with anti-YPT7 peptide antibodies, since upon reversal of
this block with excess YPT7 peptide, fusion reactions are re-
sistant to anti-Sec17p antibodies (Fig. 3 B, middle, compare
lane 2 with 3). At this stage, docking is incomplete, since af-
ter reversal of the anti-YPT7 block, reactions remain sensi-
tive to either Gdi1p/Gyp7p (Fig. 3 B, middle, lane 4),
which extracts Ypt7p (Eitzen et al., 2000), antibody to the
t-SNARE Vam3p (Fig. 3 B, middle, lane 5), or the calcium
chelator BAPTA (Fig. 3 B, middle, lane 6). The reaction
also remains sensitive to anti-Las17p antibodies after reversal
of the anti-YPT7 block (Fig. 3 B, middle, lane 7). In the
presence of BAPTA, vacuoles complete docking but do not
fuse (Peters and Mayer; 1998; Ungermann et al., 1999).
Upon reversal of the BAPTA block with calcium, vacuoles
complete fusion (Fig. 3 B, bottom, lane 2). At this stage, re-
actions are no longer sensitive to inhibitors of priming and
docking (Fig. 3 B, bottom, lanes 3–5) or to anti-Las17p an-
tibodies (Fig. 3 B, bottom, lane 7). Readdition of BAPTA
(Fig. 3 B, bottom, lane 6) or incubation on ice (Fig. 3 B,
bottom, lane 1) inhibits fusion. These data suggest that
Las17p, which helps initiate actin polymerization, may only
be needed until docking is complete, but do not specify the
reaction stage where actin functions to promote fusion.
The sensitivity of vacuole fusion to antibody to an NH
 
2
 
-
terminal region of Las17p is partially suppressed by the ad-
dition of pure recombinant WCA domain of Las17p (Fig. 3
C). The COOH-terminal WCA domain of Las17p stimu-
lates the Arp2/3 complex in yeast and higher eukaryotes
(Machesky et al., 1999; Winter et al., 1999). We also found
that addition of the CA domain partially suppresses anti-
Las17p inhibition, although less efficiently than the WCA
domain (Fig. 3 C). Whereas the CA domain of WASp acts
as a dominant-negative inhibitor in mammalian extracts
(Machesky et al., 1999), the CA domain of yeast stimulates
Arp2/3 function, though less efficiently than WCA (Winter
et al., 1999). The reaction sensitivity to anti-Las17p is also
suppressed by the addition of calmodulin (Fig. 3 C), in ac-
cord with the finding that calmodulin activates the Arp2/3
complex, which is a downstream effector of Las17p/WASp
(Schaerer-Brodbeck and Riezman, 2000a). Thus, actin re-
modeling may be at least one of the functions of calmodulin
in vacuole fusion. Calmodulin also regulates many other cel-
lular processes and specifically associates with the vacuolar
Vtc complex (Müller et al., 2002); further studies will be
needed to establish its full range of functions in vacuole fu-
sion. We also used commercially available Arp3p antibodies
to directly test the requirement of the Arp2/3 complex in
our reaction. An antibody to an NH
 
2
 
-terminal domain of
Arp3p antibody inhibits vacuole fusion, whereas antibody to
the COOH-terminal domain of Arp3 or heat-denatured an-
tibodies do not inhibit (Fig. 3 D). These biochemical studies
complement the genetic results (Fig. 2 A) and indicate that
the pathway from Cdc42p through Las17p to the Arp2/3
complex regulates vacuole fusion. Therefore, we sought di-
rect tests of the role of actin itself in vacuole fusion.
 
Actin mutations affect vacuole fusion
 
Several actin mutants were examined for their vacuole mor-
phology in vivo. Strains bearing the 
 
act1–101
 
 allele have
fragmented vacuoles, whereas strains bearing the 
 
act1–157
 
allele have abnormally large, lobed vacuoles (Fig. 2 A). Puri-
fied vacuoles from these strains, when incubated in vitro
without added cytosolic proteins, are strikingly defective for
Figure 5. Actin ligands inhibit vacuole 
fusion. (A) Inhibition of vacuole fusion 
by latrunculin B and jasplakinolide. 
Drugs were added to standard fusion 
reactions. (B) Standard vacuole fusion 
reactions were arrested while undocked 
by incubation with 64  g/ml Ypt7 
antibodies or when docked (but not fused) 
by incubation with 3.5 mM BAPTA for 
35 or 45 min, respectively. The indicated 
second inhibitors were added after 
reversal of the initial blocks by the 
addition of either 30  g/ml YPT7 peptide 
or 4 mM calcium, respectively. (C) Kinetic 
analysis of inhibition by latrunculin B. 
A large standard fusion reaction was 
incubated at 27 C. At various times, 30- l 
aliquots were placed on ice (defining 
the fusion curve) or added to tubes 
containing anti-Sec18p antibodies 
(priming curve), anti-Ypt7p antibodies 
(docking curve), or latrunculin B (300  M 
final concentration), and further 
incubated at 27 C for 90 min total. 
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in vitro fusion when compared with their isogenic 
 
ACT1
 
counterparts (Fig. 4 A, lanes 1–3). Though we have not
found conditions which allow fusion of vacuoles from the
 
act1–101
 
 strain, fusion is restored to 
 
act1–157
 
 vacuoles
when given cytosol (lane 17) or a mixture of the purified
chaperone IB2 (Slusarewicz et al., 1997), calmodulin, and
Sec18p (lane 14), a mixture which we term “pure compo-
nents” (P.C.). This agrees well with the failure of in vivo fu-
sion of 
 
act1–101
 
 vacuoles but a fused, albeit abnormal,
structure of 
 
act1–157
 
 vacuoles (Fig. 2 A). These P.C. which
stimulate salt-washed vacuoles (Ungermann et al., 1999),
also show some stimulation of wild-type (
 
ACT1
 
) vacuole fu-
sion (Fig. 4 A, compare lane 1 with 13), but only 
 
act1–157
 
vacuoles exhibit complete P.C. dependence (Fig. 4 A, com-
pare lane 2 with 14). This fusion is sensitive to normal fu-
sion inhibitors (Fig. 4 B). Immunoblot analysis was performed
on purified vacuoles from 
 
ACT1
 
,
 
 act1–157
 
, or 
 
act1–101
 
strains (Fig. 4 C). Vacuoles from actin mutant strains have
normal levels of bound proteins such as actin, calmodulin,
Sec18p, Nyv1p (v-SNARE), Ypt7p (the vacuolar Rab), and
Vps39p (a subunit of HOPS), and lumenal carboxypepti-
dase Y, showing that they are of substantially normal com-
position. However, the 
 
act1–101
 
 mutation causes a striking
deficiency in vacuolar Cla4p, Vrp1p, Las17p, and Arp3p,
though these proteins are present at normal levels in total
cell extracts (Fig. 4 D). The inability of even cytosol to res-
cue the fusion of vacuoles from 
 
act1–101
 
 strains (Fig. 4 A,
lane 18) may reflect this striking loss of actin regulatory pro-
teins. There was also a modest diminution of vacuolar
Vam3p levels (Fig. 4, C and D), which may contribute to
the fusion defect of these vacuoles.
 
Actin ligands block vacuole fusion
 
Latrunculin B and jasplakinolide bind to yeast actin mono-
mers or filaments, respectively (Ayscough 2000; Morton et
al., 2000). These drugs inhibit vacuole fusion (Fig. 5 A). As
for anti-Las17p (Fig. 3 B), reversible reaction inhibitors were
used to determine the stage at which the reaction becomes
resistant to latrunculin B or jasplakinolide (Fig. 5 B). Vacu-
oles were allowed to prime in the presence of an antibody to
a peptide from the Ypt7p sequence (Eitzen et al., 2001).
Upon addition of excess YPT7 peptide to neutralize the an-
tibody, the subsequent docking and fusion (Fig. 5 B, top,
lane 2) remained sensitive to added jasplakinolide or latrun-
culin B (Fig. 5 B, top, lanes 6 and 7). In a parallel incuba-
tion, vacuoles were allowed to complete docking in the pres-
ence of the fusion inhibitor BAPTA. Upon reversal of the
BAPTA block, the vacuoles went on to fuse when incubated
at 27
 
 
 
C (Fig. 5 B, bottom, lane 2). Fusion was no longer
sensitive to Gdi1p/Gyp7p or anti-Vam3p antibodies, though
these blocked the reaction completely if added from the start
(unpublished data), indicating that the vacuoles had com-
pleted docking in the presence of BAPTA (Peters and
Mayer, 1998; Ungermann et al., 1999). Although latruncu-
lin B still inhibited the fusion of these docked vacuoles (Fig.
5 B, bottom, lane 7), jasplakinolide did not (Fig. 5 B, bot-
tom, lane 6). To verify that latrunculin acts as a late stage in-
hibitor of vacuole fusion, its kinetics of inhibition were ex-
amined. The drug was added to aliquots of a standard fusion
reaction at various times, and each aliquot was further incu-
bated for a total time of 90 min at 27
 
 
 
C. Latrunculin addi-
tion yielded a kinetic curve of inhibition that was similar to
samples placed on ice, which represents the membrane fu-
sion curve (Fig. 5 C). The curve of acquired resistance to la-
trunculin B was well resolved from the kinetics of acquiring
resistance to priming (anti-Sec18p) and docking (anti-
Ypt7p) inhibitors. Together, these data suggest that actin
remodeling, revealed by sensitivity of the vacuole fusion re-
action to anti-Las17p or jasplakinolide, occurs during dock-
ing, although the formation of F-actin from monomer,
Figure 6. Actin remodeling is not needed for Ypt7-dependent 
docking. The quantitative microscopic assay of vacuole docking 
was performed as described (Wang et al., 2002). Approximately 
700 vacuoles were counted for each reaction, and the percentage 
of vacuoles in each cluster size was scored. Gdi1p (100  g/ml), 
jasplakinolide (250  M), and latruculin B (400  M) were added 
as indicated. 
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shown by latrunculin B sensitivity, is needed during mem-
brane fusion.
To determine whether actin remodeling is needed for
docking itself or whether it is only needed during docking to
allow subsequent fusion, we performed a quantitative micro-
scopic assay of docking (Mayer and Wickner, 1997; Wang
et al., 2002). During our standard in vitro incubations,
docking creates large clusters of five or more vacuoles (Fig. 6
B). Docking requires ATP-dependent priming (Fig. 6 A)
and is blocked by the extraction of Ypt7p by Gdi1p (Fig. 6
C). Neither jasplakinolide nor latrunculin B, at concentra-
tions which block the fusion reaction, inhibit the formation
of docked vacuole clusters (Fig. 6, D and F), and docking re-
mains sensitive to Gdi1p (i.e., Ypt7p dependent) in the pres-
ence of either drug (Fig. 6, E and G). Thus actin is needed
for vacuole fusion rather than for docking, though the jas-
plakinolide-sensitive aspects of actin remodeling occur dur-
ing the docking reaction.
 
Vertex enrichment of actin
 
We have defined the membrane microdomains of docked
vacuoles as outside (not in contact with another vacuole),
boundary (apposed to another vacuole in a docked cluster),
or vertex (where boundary membranes, or outside and
boundary membranes, meet). The vertices form a ring
around the boundary membrane of adjacent vacuoles, and
vacuole homotypic fusion occurs at this ring in vivo and in
vitro (Wang et al., 2002). Proteins which catalyze docking
and fusion are enriched at these vertex rings, providing a
mechanistic rationale for the observed vertex ring fusion
pathway. Since actin is required for vacuole fusion, we tested
whether it accumulates at the vertex rings of docked vacu-
oles. Rhodamine-labeled rabbit muscle G-actin was added to
vacuoles in the presence of the lipophilic dye MDY-64.
When these vacuoles were clumped by cosedimentation
(Fig. 7 A, top), there was no apparent clustering of bound
actin at any microdomain. However, when these vacuoles
were incubated under authentic docking conditions (Fig. 7
A, middle), actin bound selectively to the vertices as shown
by ratiometric analysis of the two fluors. This vertex enrich-
ment, like those seen for other docking and fusion factors
(Wang et al., 2002), is prevented when SNARE disassembly
is blocked (Wang et al., 2000) by an added excess of Sec17p
(Fig. 7 A, bottom).
A similar pattern of vertex-specific labeling was seen with
vacuoles which formed docked clusters in the presence of Al-
 
Figure 7.
 
Actin is enriched at the vertices of docked vacuoles.
 
 
Purified vacuoles were either docked by the physiological Ypt7p-
dependent pathway or clustered by cosedimentation as described in 
Wang et al. (2002). (A) Rhodamine-actin (4 
 
 
 
M, total rabbit muscle 
actin) was added at the beginning of the reaction, or Alexa Fluor 
488–DNaseI (0.2 
 
 
 
M) was added to docked or cosedimented vacuoles 
(B). After a 30-min incubation at 27
 
 
 
C, vacuoles were fixed with 1% 
formaldehyde for 20 min at room temperature, sedimented at 3000 
 
g
 
 
for 2 min, resuspended in PS buffer, and subjected to microscopic 
analysis (as described in Materials and methods). Ratiometric images of 
representative clusters are shown. (C) Cumulative distribution plots 
of the ratios of pixel values (rhodamine:MDY-64 lipid label) 
obtained for each morphometric domain (vertex, boundary, and 
outside edge midpoints) and each treatment. Each curve represents 
an average of 410 individual ratio measurements on 110–115 
vacuole clusters from three independent experiments. 
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exa Fluor 488–labeled DNaseI (Fig. 7 B). DNaseI binds se-
lectively to actin and thus serves as a measure of the spatial
distribution of vacuole-bound actin. Quantitation of the
ratios of Alexa Fluor 488–DNaseI to lipidic fluor was per-
formed for the outside edge, boundary midpoints, and vertices
of many vacuole clusters. Each ratio was plotted according
to its percentile value in its cohort (Fig. 7 C), showing that
there is a clear enrichment of Alexa Fluor 488–DNaseI–dec-
orated actin at the vertices of vacuoles under authentic dock-
ing conditions.
 
Discussion
 
Our studies show that vacuole-bound actin is needed for ho-
motypic fusion of this organelle in the absence of cytoskele-
ton or cytosol. Proteins of the well-established pathways of
actin cytoskeleton regulation are needed for normal vacuole
structure in vivo (Fig. 2 A) and are found on purified vacu-
oles at levels which cannot be due to cytosolic contamina-
tion (Fig. 2 B). Antibody to the Las17p/Bee1p, the yeast
WASp homologue, inhibits vacuole fusion (Fig. 3), and this
inhibition can be modulated (Fig. 3 C) by high levels of ei-
ther the WCA domain of Las17p or by calmodulin, which
are known to interact directly with Arp2/3 complex. Anti-
body to Arp3p itself also blocks vacuole fusion (Fig. 3 D).
Mutations in actin have striking effects on vacuole structure
in vivo (Fig. 2 A) and fusion in vitro (Fig. 4), and well-stud-
ied actin ligands (Morton et al., 2000) show fusion stage-
specific inhibition of the vacuole fusion reaction (Figs. 5 and
6). We found that blocking F-actin depolymerization (jas-
plakinolide) no longer inhibits vacuoles that have undergone
docking (BAPTA block), whereas blocking F-actin assembly
with latrunculin B still prevents the final stage of membrane
fusion (Fig. 5 B). These results suggest that disassembly of
actin, though not needed for docking, is required to produce
fusion-competent docked vacuoles and that actin reassembly
is needed for fusion. Thus Cdc42p may be essential for vac-
uole fusion (Eitzen et al., 2001; Müller et al., 2001) because
it governs the state of vacuole-bound actin. Rho1p may even
regulate vacuole fusion by controlling actin via a MAPK cas-
cade (Helliwell et al., 1998).
Actin is required for other yeast trafficking reactions as well.
However, it is unclear in these studies whether this reflects a
need for actin cytoskeleton or for actin on the surface of or-
ganelles. Actin is needed for mitochondrial motility (Simon et
al., 1995) and inheritance (Hermann et al., 1997; Boldogh et
al., 2001), vacuole inheritance (Hill et al., 1996), and the po-
larized delivery of secretory vesicles to the bud tip (Novick
and Botstein, 1985; Mullholland et al., 1997; Pruyne et al.,
1998). Cdc42p regulates polarized exocytosis in yeast (Pringle
et al., 1995; Zhang et al., 2001) and controls actin polymer-
ization through activation of Las17p and the Arp2/3 complex
(Lechler et al., 2001). Cdc42p also interacts with proteins
that mediate secretory vesicle docking and fusion in a manner
that is independent of actin cytoskeleton (Adamo et al., 2001;
Zhang et al., 2001). It is unclear though whether Cdc42p also
controls actin-related organelle inheritance.
Actin and its regulatory proteins are required for endocy-
tosis in yeast (Kubler and Riezman, 1993; Munn et al.,
1995; Geli and Riezman, 1996) and mammals (Lamaze et
al., 1997). These actin regulatory proteins include Myo5p
(Geli et al., 1998), calmodulin (Kubler et al., 1994), which
is also needed for vacuole homotypic fusion (Peters and
Mayer, 1998), Arc35p (Schaerer-Brodbeck and Riezman,
2000b), a subunit of the Arp2/3 complex, and Pan1p, which
interacts with the endocytic machinery and activates the
Arp2/3 complex (Duncan et al., 2001).
Immunoblot analysis of purified vacuoles and whole cell
lysate revealed an enrichment of actin regulatory proteins
from Cdc42p to the Arp2/3 complex on the vacuole mem-
brane (Fig. 2). Although the Arp2/3 complex or its sub-
components have not previously been localized to the vacu-
ole membrane, they have been found on other subcellular
organelles such as the nucleus (Weber et al., 1995; Yan et
al., 1997) and the mitochondria (Boldogh et al., 2001). We
now show that these proteins, which are part of a well-stud-
ied actin remodeling cascade (Higgs and Pollard, 1999), also
regulate membrane fusion. Clearly the major site of Arp2/3
localization is cortical actin patches at the plasma mem-
brane where it is involved in cell growth via regulation of
vesicle delivery (Moreau et al., 1996; Lechler et al., 2001),
though these studies did not preclude a continuing role in
vesicle docking and membrane fusion. In addition to
Arp3p and Las17p antibody inhibition, we also show that
calmodulin and Las17p WCA domain, which are known to
interact with and stimulate Arp2/3 function (Winter et
al., 1999; Schaerer-Brodbeck and Riezman, 2000b), can
stimulate membrane fusion of vacuoles which have been
blocked by the addition of an NH
 
2
 
-terminal Las17p pep-
tide antibody (Fig. 3 C). Additionally, specific actin muta-
tions cause the striking loss of vacuolar localization of sev-
eral actin regulatory proteins, coincident with the inability
of these vacuoles to fuse in vitro (Fig. 4 C). These data thus
establish a requirement for actin remodeling for vacuole
fusion.
Part of the functions of calmodulin and PI(4,5)P2 in vac-
uole fusion may be the regulation of actin. Calmodulin me-
diates the signal of docking-induced calcium release (Peters
and Mayer, 1998). It interacts directly with the V
 
o
 
 and Vtc
complexes (Peters et al., 2001; Müller et al., 2002), Myo2p
(Cheney et al., 1993; Brockerhoff et al., 1994), and the
Arp2/3 complex (Schaerer-Brodbeck and Riezman, 2000b).
Our current studies (Fig. 3 C) show that calmodulin can at
least partially bypass the inhibition caused by antibody to
Las17p. Genetic (Seeley et al., 2002) and biochemical
(Mayer et al., 2000) data show that PI(4,5)P2 is required for
vacuole fusion, perhaps in part to function as a guanine nu-
cleotide exchange factor for Cdc42p (Zheng et al., 1996) or
as an activating ligand for Las17p. PI(4)P 5-kinase has been
shown to govern actin polymerization in yeast (Desrivieres
et al., 1998) and mammals (Shibasaki et al., 1997).
Although our combined genetic and biochemical data
clearly show that actin has a central role in vacuole fusion,
the regulation of this process and the mode of actin action
are unknown. Actin structure is altered by overexpression of
Nrf1p (Murray and Johnson, 2000), a protein which is di-
rectly involved in vacuole fusion (Müller et al., 2002) and
interacts genetically with Cdc42p (Murray and Johnson,
2000). Actin remodeling on the vacuole is regulated by the
Cdc42p–Las17p–Arp2/3 cascade. Though Cdc42p action 
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requires the prior activation of Ypt7p (Eitzen et al., 2001),
the mechanisms which connect these GTPases are unclear.
Recently, we reported (Wang et al., 2002) that docked vacu-
oles show selective accumulation of fusion proteins at a ring
around the edge of their apposed membranes and that this
ring is the site of membrane fusion. Vacuolar-bound actin is
also enriched at these vertices during docking (Fig. 7). Ver-
tex enrichment is a critical subreaction of membrane fusion
(Wang et al., 2002). Actin may contribute to this protein lo-
calization and might distort or destabilize the bilayer mem-
brane on each vacuole as a prerequisite to fusion itself.
 
Materials and methods
 
Yeast strains and genetic modifications
 
Yeast strains are listed in Table I. The endogenous 
 
ACT1
 
 gene was re-
placed with the 
 
act1–101
 
 and act1–157 mutant alleles or wild-type ACT1
(including the downstream HIS3 gene) by PCR amplification from strains
DDY 338, DDY1544, and DDY354, respectively (Holtzman et al., 1994;
Belmont et al., 1999) using primers TCTACTACATCAGCTTTTAG and
GAAGGGCAATTGCATAAAC. Transformants were selected on SD-his
(Bio101). Proper integration was checked by genomic DNA PCR using
primers AATCTTTGTTAAAGAATAGG and CTAATGGCGGTTCTACAAG.
In vivo vacuole morphology was examined by fluorescence microscopy
after FM4–64 staining (Seeley et al., 2002).
Biochemical reagents
Reagents were dissolved or dialyzed in PS buffer (20 mM PIPES-KOH, pH
6.8, 200 mM sorbitol) unless otherwise noted. Alexa Fluor 488–DNaseI
(Molecular Probes) was dissolved in PBS/50% glycerol at 166  M, and
rhodamine-labeled rabbit actin (a gift from Dr. H. Higgs, Dartmouth Med-
ical School) was a mixture of 30  M unlabeled actin and 10  M labeled
actin. Jasplakinolide (Molecular Probes) and latrunculin B (Biomol) were
dissolved in DMSO at 10 mM. Amino (yG18) and carboxy (yK17) Arp3p
antibodies (Santa Cruz Biotechnology, Inc.) were dialyzed into PS buffer.
The following inhibitors were used at the final concentrations listed: affin-
ity-purified anti-YPT7 peptide antibodies (50  g/ml), IgG fraction of anti-
Las17 peptide antibodies (350  g/ml), affinity-purified anti-Sec18p anti-
bodies (50  g/ml), anti-Vam3p IgG (150  g/ml), anti-Sec17p IgG (250  g/
ml), Arp3p IgGs (300  g/ml), Gdi1p (100  g/ml), Gyp7p (30  g/ml),
Rdi1p (500  g/ml), latrunculin B (400  M), jasplakinolide (250  M), and
BAPTA (5 mM).
Protein preparation
Sec18p, Gyp7p, Gdi1p, Rdi1p, calmodulin (Cmd)1p, and IB2 were prepared
as described (Brockerhoff et al., 1992; Slusarewicz et al., 1997; Eitzen et al.,
2001). GST, GST–WCA, and GST–CA were expressed in Escherichia coli
DH5  transformed with the vector pGEX-4T1 (Amersham Biosciences) only
or with vector containing in frame BamH1–EcoR1PCR products encoding
the COOH-terminal 125 (WCA) or 66 (CA) amino acids of Las17p. These
proteins were prepared as described for Rdi1p (Eitzen et al., 2001). Cytosol
was prepared from strain K91–1A grown to an OD600  4, lysed by vortexing
5 min with glass beads in lysis buffer (125 mM KCl, 5 mM MgCl2, 20 mM
PIPES-KOH, pH 6.8, 200 mM sorbitol, 1 mM ATP, 6.6 ng/ml leupeptin, 16.6
ng/ml pepstatin, 16.6  M  o-phenanthroline, 3.3  M Pefabloc SC), and
cleared by centrifugation (12,000 g for 10 min and then 150,000 g for 60
min at 4 C). Whole cell lysates were similarly prepared in lysis buffer from
strains grown to an OD600  1 except that 1% Triton X-100 was added after
glass bead vortexing and the lysate was cleared by centrifugation at 3,000 g
for 4 min at 4 C. YPT7 and LAS17 peptide antibodies were raised against
TEAFEDDYNDAINIRC and FEMEECFAGLLFVDINEASHC conjugated to
KLH, respectively. These peptides (3 mg/ml resin) and Sec18p (10 mg/ml
resin) were conjugated to Sulfolink resin (Pierce Chemical Co.) according to
the manufacturer’s protocol. IgG fractions were prepared from sera by pro-
tein A sepharose adsorption (Harlow and Lane, 1988). Immobilized peptides
and protein were used for affinity purification and immunodepletion of anti-
bodies. For immunodepletion experiments, IgGs (0.5 ml) were incubated
with 0.1 ml packed resin in PBS for 1 h at 4 C. Flow-through samples were
saved as immunodepleted fractions. The resin was washed twice with 1 ml
of PBS, and bound antibodies were eluted with 0.25 ml of 100 mM glycine-
HCl, pH 2.5. All samples were dialyzed into PS buffer.
Standard vacuole fusion reactions
Vacuoles were isolated from strains grown in YPD to an OD600  0.9. Fu-
sion reactions (Haas, 1995) contain 3  g of vacuoles lacking proteinase A
and 3  g of vacuoles lacking alkaline phosphatase in 30  l fusion reaction
buffer (FRB: 125 mM KCl, 5 mM MgCl2, 20 mM PIPES-KOH, pH 6.8, 200
mM sorbitol, 1 mM ATP, 40 mM creatine phosphate, 0.5 mg/ml creatine
kinase, 10  M CoA, 6.6 ng/ml leupeptin, 16.6 ng/ml pepstatin, 16.6  M
o-phenanthroline, 3.3  M Pefabloc SC). Standard vacuole fusion reactions
also contained P.C. (200  g/ml calmodulin, 8  g/ml IB2, and 1  g/ml
Sec18p). Reactions were incubated for 90 min at 27 C before assaying for
alkaline phosphatase. Staging experiments with reversible blocking re-
agents were as described previously (Eitzen et al., 2001).
Table I. Yeast strains
Strain Genotype Source
K91-1A Mata, ura3, lys1,  pho8::AL134,  pho13::pPH13 Y. Kaneko
a
DKY6281 Mat , his3, leu2, ura3, lys2,  suc2,  pho8::TRP1 D. Klionsky
b
RLY 574 Mat , his3, leu2, trp1,  arp2::TRP1 R. Li
c
DDY2266 Mata, his3, leu2, ura3 lys2,, las17-16::LEU2 D. Drubin
d
BY4742 Mat , his3 1, leu2 0, ura3 0, lys2 0  Research Genetic
GEY1290 BY4742,  myo3::kanMx Research Genetic
GEY1090 BY4742,  myo5::kanMx Research Genetic
GEY4840 BY4742,  sac2::kanMx Research Genetic
GEY1290 BY4742,  sac6::kanMx Research Genetic
GEY3370 BY4742,  vrp1::kanMx Research Genetic
GEY2980 BY4742,  cla4::kanMx Research Genetic
GEY3700 BY4742,  arc18::kanMx Research Genetic
GEY6024 BY4742,  pep4::kanMx Research Genetic
GEY6028 BY4742,  pho8::kanMx Research Genetic
GEY0394 BY4742,  pep4::kanMx,  act1::ACT1(HIS3) This study
GEY0398 BY4742,  pho8::kanMx,  act1::ACT1(HIS3) This study
GEY0394-101 BY4742, vpep4::kanMx,  act1::act1-101(HIS3) This study
GEY0398-101 BY4742,  pho8::kanMx,  act1::act1-101(HIS3) This study
GEY0394-157 BY4742,  pep4::kanMx,  act1::act1-157(HIS3) This study
GEY0398-157 BY4742,  pho8::kanMx,  act1::act1-157(HIS3) This study
aOsaka University, Osaka, Japan.
bUniversity of Michigan, Ann Arbor, MI.
cHarvard Medical School, Boston, MA.
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In vitro microscopic docking assay and image processing
Docking assays were performed as described previously (Wang et al.,
2002) with minor modifications. Reactions (30  l) contain 5  g of vacu-
oles (from strain DKY6281) labeled with the lipophilic dye MDY-64 (3
 M; Molecular Probes). At the end of the reaction, vacuoles were mixed
with 40  l of 0.6% agarose in PS buffer. Aliquots (15  l) were then ob-
served by fluorescence microscopy. Images were acquired with an Olym-
pus BX51 microscope equipped with a 60 /1.4 NA plan Apochromat ob-
jective, 100 W Mercury arc lamp, and Cooke Sensicam QE CCD camera.
The microscope and camera were controlled by IP lab software (Scanalyt-
ics). An Endow GFP filter cube (Chroma Technology Corp.) was used for
rhodamine-actin and Alexa Fluor 488–DNaseI. The camera was operated
at normal gain setting without binning. An automation script was written to
facilitate reproducible image acquisition. Image processing and quantita-
tive analysis were according to Wang et al. (2002).
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